Page last updated: 2024-11-05

tetrahydrofurfuryl methacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tetrahydrofurfuryl methacrylate (THFMA) is a colorless liquid monomer that is used in the production of polymers, resins, and coatings. It is synthesized by the reaction of methacrylic acid with tetrahydrofurfuryl alcohol. THFMA is known for its good adhesion, flexibility, and water resistance. It is commonly used in the formulation of acrylic resins for coatings, adhesives, and sealants. THFMA is also used in the production of dental composites and biocompatible materials. The study of THFMA is motivated by its versatility in polymer chemistry and its potential applications in various industries. Researchers are interested in exploring its properties, including its reactivity, polymerization behavior, and biocompatibility, to further develop new and improved materials.'

Cross-References

ID SourceID
PubMed CID17151
CHEMBL ID3561338
CHEBI ID189338
SCHEMBL ID36133
MeSH IDM0245123

Synonyms (50)

Synonym
methacrylic acid, tetrahydrofurfuryl ester
sr 203
nsc-32634
2455-24-5
tetrahydrofurfuryl methacrylate
sartomer sr 203
nsc32634
tetrahydrofuran-2-ylmethyl 2-methylprop-2-enoate
tetrahydrofurfuryl methacrylate, contains 75 ppm hq as inhibitor, 900 ppm mehq as inhibitor, 97%
nsc 32634
methacrylic acid tetrahydrofurfuryl ester
ai3-08497
2-propenoic acid, 2-methyl-, (tetrahydro-2-furanyl)methyl ester
tetrahydrofurfurylmethacrylate
einecs 219-529-5
hsdb 5461
FT-0693996
M0745
oxolan-2-ylmethyl 2-methylprop-2-enoate
CHEBI:189338
unii-120gn9c472
120gn9c472 ,
dtxcid502191
dtxsid0022191 ,
cas-2455-24-5
tox21_301715
NCGC00255107-01
SCHEMBL36133
tetrahydrofurfuryl methacrylate [inci]
furfuryl alcohol, tetrahydro-, methacrylate
acryester thf
tetrahydrofurfurylmethacrylate [hsdb]
ageflex thfma
W-109786
AKOS024437822
CHEMBL3561338
(oxolan-2-yl)methyl 2-methylprop-2-enoate
AS-71548
tetrahydrofurfuryl methacrylate, (stabilized with mehq)
tetrahydrofurfuryl methacrylate (stabilized with mehq)
tetrahydrofurfuryl methacrylate, 97%, contains 900 ppm mehq as stabilizer
?tetrahydrofurfuryl methacrylate
(tetrahydrofuran-2-yl)methyl methacrylate
mfcd00014515
STL558995
Q20054551
BBL036434
D97782
SY049908
(tetrahydrofuran-2-yl)methylmethacrylate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxolanesAny oxacycle having an oxolane (tetrahydrofuran) skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency48.55770.000714.592883.7951AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159553; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency27.30600.005428.02631,258.9301AID1346982
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (29.17)18.2507
2000's10 (41.67)29.6817
2010's6 (25.00)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.87 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]